Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.000
-0.090 (-8.26%)
Nov 4, 2024, 4:00 PM EST - Market closed
Biofrontera Employees
As of December 31, 2023, Biofrontera had 85 total employees, including 83 full-time and 2 part-time employees. The number of employees increased by 4 or 4.94% compared to the previous year.
Employees
85
Change (1Y)
4
Growth (1Y)
4.94%
Revenue / Employee
$414,600
Profits / Employee
-$158,941
Market Cap
5.54M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 85 | 4 | 4.94% |
Dec 31, 2022 | 81 | 12 | 17.39% |
Dec 31, 2021 | 69 | 13 | 23.21% |
Dec 31, 2020 | 56 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Mainz Biomed | 71 |
Kindly MD | 65 |
Sunshine Biopharma | 44 |
Windtree Therapeutics | 20 |
Purple Biotech | 20 |
Eterna Therapeutics | 8 |
Portage Biotech | 7 |
Xenetic Biosciences | 4 |
BFRI News
- 3 days ago - Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024 - Accesswire
- 4 days ago - Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC) - GlobeNewsWire
- 21 days ago - Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC) - GlobeNewsWire
- 4 weeks ago - FDA Approves Use of Up To Three Tubes of Biofrontera Inc.'s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment - GlobeNewsWire
- 5 weeks ago - Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference - Accesswire
- 2 months ago - Biofrontera Inc. (BFRI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 3 months ago - Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024 - Accesswire